Reaction
Ileostomy Closure reporting signals
As of the last recalculation, Ileostomy Closure appears in 324 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is RISANKIZUMAB-RZAA (PRR 39.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Risankizumab-Rzaa | 44 | 39.8 | 39.9 |
| Teduglutide | 7 | 34.1 | 34.1 |
| Panitumumab | 7 | 29.3 | 29.3 |